US Bancorp’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$475K Sell
15,093
-3,346
-18% -$105K ﹤0.01% 1536
2025
Q4
$543K Buy
18,439
+1,359
+8% +$37.8K ﹤0.01% 1490
2025
Q3
$431K Sell
17,080
-2,335
-12% -$56.9K ﹤0.01% 1599
2025
Q2
$466K Sell
19,415
-12,117
-38% -$281K ﹤0.01% 1534
2025
Q1
$722K Sell
31,532
-6,587
-17% -$159K ﹤0.01% 1260
2024
Q4
$965K Sell
38,119
-8,026
-17% -$203K ﹤0.01% 1133
2024
Q3
$1.15M Sell
46,145
-8,917
-16% -$264K ﹤0.01% 1071
2024
Q2
$1.63M Buy
55,062
+800
+1% +$22.2K ﹤0.01% 915
2024
Q1
$1.64M Sell
54,262
-212
-0.4% -$5.88K ﹤0.01% 915
2023
Q4
$1.56M Sell
54,474
-11,006
-17% -$323K ﹤0.01% 923
2023
Q3
$2.43M Buy
65,480
+1,643
+3% +$62.8K ﹤0.01% 740
2023
Q2
$2.49M Buy
63,837
+973
+2% +$38.1K ﹤0.01% 728
2023
Q1
$2.3M Buy
62,864
+4,001
+7% +$126K ﹤0.01% 761
2022
Q4
$1.81M Buy
+58,863
New +$1.83M ﹤0.01% 840

Other funds holding RTO

US Bancorp's RTO Position: Q1 2026 in Review

US Bancorp reduced its Rentokil (RTO) stake by 18% in Q1 2026, selling an estimated $105K and leaving 15,093 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

US Bancorp first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.49M in Q2 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • US Bancorp held 15,093 shares of Rentokil worth $475K as of Q1 2026.
  • US Bancorp sold 3,346 Rentokil shares in Q1 2026, an estimated $105K.
  • Rentokil made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1536 holding.
  • US Bancorp first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • US Bancorp's Rentokil position peaked at $2.49M in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.